Urgent Product Recall: Accu-Chek Solo cannula assembly and pump holder and Accu-Chek Solo supply kit 22 December 2022 The Therapeutic Goods Administration (TGA) and Roche Diabetes Care have issued an urgent medical device recall for Accu-Chek Solo cannula assembly and pump holder, and the supply kit. Roche Diabetes Care has identified that insulin leakage has occurred in a small number of cases with the Accu-Chek Solo cannula assembly and pump holder (6mm and 9mm, NDSS codes 851 and 852) and the Accu-Chek Solo supply kit (6mm and 9mm). Discontinue use of these products immediately. The insulin leakage may not be noticed straight away, which could lead to an under-delivery of insulin. The possible consequences could range from no clinical impact to severe hypoglycaemia (dangerously low blood glucose levels) or diabetic ketoacidosis (DKA). Please contact Roche Diabetes customer care on 1800 251 816 for information on how to return the impacted stock and receive the replacement. The complete recall notice from the TGA is available here.
Media releases 30 April 2025 Melbourne to host International Diabetes Congress amid rising health crisis In a major win for Australia’s diabetes community, the International Diabetes Federation Western Pacific Region (IDF WPR) Congress 2026 will... Continue Reading
Media releases 28 April 2025 New nib foundation partnership to enhance diabetes care for people living with disability A groundbreaking new partnership between Diabetes Australia and nib foundation will improve the lives of people living with both diabetes... Continue Reading
Media releases 8 April 2025 New data reveals diabetes prevalence in Australia may be 35% higher New research from the University of Sydney reveals that the number of Australians living with diabetes may be up to... Continue Reading